Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × flibanserin × Genitourinary × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostate Adenocarcinoma 1

Interventions

pembrolizumab 63 Nivolumab 54 Magnetic Resonance Spectroscopy 48 enzalutamide 35 Prednisone 34 Gemcitabine 34 Radiosurgery 33 Abiraterone Acetate 33 Ipilimumab 30 Radiotherapy 29 Docetaxel 28 Specimen Handling 27 Cisplatin 27 apalutamide 26 Androgen Antagonists 25 Leuprolide 24 Carboplatin 22 atezolizumab 21 durvalumab 20 cabozantinib 20 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 17 Goserelin 17 Gonadotropin-Releasing Hormone 17 Biopsy 16 Radiation 15 olaparib 14 darolutamide 14 gallium 68 PSMA-11 13 bicalutamide 13 belzutifan 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04743934 2025-05-04

RAD 2003

University of Alabama at Birmingham

Phase 2 Active not recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡